BACKGROUND: Non-surgical treatment for stress urinary incontinence (SUI) is recommended as first-line therapy, yet few prospective studies and no randomized trials compare the most common non-surgical treatments for SUI. PURPOSE: To present the design and methodology of the ambulatory treatments for leakage associated with stress (ATLAS) trial, a randomized clinical trial comparing three interventions for predominant SUI in women: intravaginal continence pessary; behavioral therapy (including pelvic floor muscle training and exercise and bladder control strategies); and a combination of the two treatments. METHODS: Treatment outcome measures, collected at 12 weeks and six and 12 months post randomization, include the Patient Global Impression of Improvement (PGI-I), the Stress Incontinence Scale of the Pelvic Floor Distress Inventory (PFDI), seven-day bladder diaries, Pelvic Floor Impact Questionnaire (PFIQ), Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire (PISQ-12), Patient Satisfaction Questionnaire (PSQ) and the Medical Outcomes Study Short Form Health Survey (SF-36). LIMITATIONS: The study design reduces most common biases, but some degree of selection bias may remain. CONCLUSION: This trial will provide useful information to help counsel women with stress and mixed incontinence about the relative efficacy and satisfaction with pessary, behavioral therapy and both treatments combined.
RCT Entities:
BACKGROUND: Non-surgical treatment for stress urinary incontinence (SUI) is recommended as first-line therapy, yet few prospective studies and no randomized trials compare the most common non-surgical treatments for SUI. PURPOSE: To present the design and methodology of the ambulatory treatments for leakage associated with stress (ATLAS) trial, a randomized clinical trial comparing three interventions for predominant SUI in women: intravaginal continence pessary; behavioral therapy (including pelvic floor muscle training and exercise and bladder control strategies); and a combination of the two treatments. METHODS: Treatment outcome measures, collected at 12 weeks and six and 12 months post randomization, include the Patient Global Impression of Improvement (PGI-I), the Stress Incontinence Scale of the Pelvic Floor Distress Inventory (PFDI), seven-day bladder diaries, Pelvic Floor Impact Questionnaire (PFIQ), Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire (PISQ-12), Patient Satisfaction Questionnaire (PSQ) and the Medical Outcomes Study Short Form Health Survey (SF-36). LIMITATIONS: The study design reduces most common biases, but some degree of selection bias may remain. CONCLUSION: This trial will provide useful information to help counsel women with stress and mixed incontinence about the relative efficacy and satisfaction with pessary, behavioral therapy and both treatments combined.
Authors: Linda Brubaker; Matthew D Barber; Ingrid Nygaard; Charlie W Nager; Edward Varner; Joseph Schaffer; Anthony Visco; Susan Meikle; Cathie Spino Journal: Am J Obstet Gynecol Date: 2010-08-21 Impact factor: 8.661
Authors: Holly E Richter; Kathryn L Burgio; Linda Brubaker; Ingrid E Nygaard; Wen Ye; Alison Weidner; Catherine S Bradley; Victoria L Handa; Diane Borello-France; Patricia S Goode; Halina Zyczynski; Emily S Lukacz; Joseph Schaffer; Matthew Barber; Susan Meikle; Cathie Spino Journal: Obstet Gynecol Date: 2010-03 Impact factor: 7.661
Authors: Victoria L Handa; Emily Whitcomb; Alison C Weidner; Ingrid Nygaard; Linda Brubaker; Catherine S Bradley; Marie Fidela R Paraiso; Joseph Schaffer; Halina M Zyczynski; Min Zhang; Holly E Richter Journal: Female Pelvic Med Reconstr Surg Date: 2011 Impact factor: 2.091
Authors: Catherine S Bradley; David D Rahn; Ingrid E Nygaard; Matthew D Barber; Charles W Nager; Kimberly S Kenton; Nazema Y Siddiqui; Robert B Abel; Cathie Spino; Holly E Richter Journal: Neurourol Urodyn Date: 2010-06 Impact factor: 2.696
Authors: Tamara G Bavendam; Jenna M Norton; Ziya Kirkali; Chris Mullins; John W Kusek; Robert A Star; Griffin P Rodgers Journal: J Urol Date: 2016-06-21 Impact factor: 7.450
Authors: Joseph Schaffer; Charles W Nager; Fang Xiang; Diane Borello-France; Catherine S Bradley; Jennifer M Wu; Elizabeth Mueller; Peggy Norton; Marie Fidela R Paraiso; Halina Zyczynski; Holly E Richter Journal: Obstet Gynecol Date: 2012-07 Impact factor: 7.661